224
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Castrate-resistant prostate cancer: therapeutic strategies

, MD & , MD
Pages 937-945 | Published online: 22 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David Shapiro & Basir Tareen. (2012) Current and emerging treatments in the management of castration-resistant prostate cancer. Expert Review of Anticancer Therapy 12:7, pages 951-964.
Read now

Articles from other publishers (10)

Agus Rizal A. H. Hamid, Harun W. Kusuma Putra, Ningrum Paramita Sari, Putri Diana, Saras Serani Sesari, Eka Novita, Fajar Lamhot Gultom, Meilania Saraswati, Budiana Tanurahardja, Asmarinah, Rainy Umbas & Chaidir A. Mochtar. (2020) Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy. BMC Urology 20:1.
Crossref
Daniel J. Lee & Neal D. Shore. 2018. Prostate Cancer. Prostate Cancer 121 134 .
JGC van Hasselt, A Gupta, Z Hussein, JH Beijnen, JHM Schellens & ADR Huitema. (2015) Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin. CPT: Pharmacometrics & Systems Pharmacology 4:7, pages 386-395.
Crossref
FENG-QIANG YANG, MIN LIU, WEI LI, JIAN-PING CHE, GUANG-CHUN WANG & JUN-HUA ZHENG. (2015) Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Molecular Medicine Reports 11:2, pages 1085-1092.
Crossref
Nerea Gallastegui & Eva Estébanez-Perpiñá. 2015. Nuclear Receptors: From Structure to the Clinic. Nuclear Receptors: From Structure to the Clinic 179 203 .
Jorge A.R. Salvador, Rui M.A. Pinto & Samuel M. Silvestre. (2013) Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 199-222.
Crossref
Lei Wang, Jeffrey Ho, Carlotta Glackin & Manuela Martins-Green. (2012) Specific Pomegranate Juice Components as Potential Inhibitors of Prostate Cancer Metastasis. Translational Oncology 5:5, pages 344-IN5.
Crossref
Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa & Shahrokh F. Shariat. (2011) Novel therapeutics for the management of castration‐resistant prostate cancer (CRPC). BJU International 109:7, pages 968-985.
Crossref
Michell B. Redding & Minal Surati. (2011) Emerging Treatments for Castrate-Resistant Prostate Cancer. Journal of Pharmacy Practice 24:4, pages 366-373.
Crossref
Yuka NakajimaKensuke AkaogiTakashi SuzukiAsami OsakabeChie YamaguchiNanae SunaharaJunji IshidaKoichiro KakoSonoko OgawaTetsuya FujimuraYukio HommaAkiyoshi FukamizuAkiko MurayamaKeiji KimuraSatoshi InoueJunn Yanagisawa. (2011) Estrogen Regulates Tumor Growth Through a Nonclassical Pathway that Includes the Transcription Factors ERβ and KLF5. Science Signaling 4:168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.